www.kff.org/affordable-c...
www.kff.org/affordable-c...
Post-Ipsos: 23% support/42% oppose/34% no opin
KFF: 35% favorable/64% unfave
Pew: 29% favor/49% oppose/21% not sure
Economist/YouGov: 35%-51% support-oppose
www.washingtonpost.com/politics/202...
www.kff.org/medicaid/pol...
www.pewresearch.org/short-reads/...
🔗: on.kff.org/3Zywm9K
www.kff.org/racial-equit...
www.kff.org/racial-equit...
www.kff.org/health-infor...
www.kff.org/health-infor...
www.kff.org/medicaid/pol...
www.kff.org/medicaid/pol...
www.kff.org/quick-take/t...
www.kff.org/quick-take/t...
www.kff.org/medicaid/pol...
www.kff.org/medicaid/pol...
www.kff.org/global-healt...
www.kff.org/global-healt...
The last few weeks saw vital public data from the Census and other government surveys being taken offline. These surveys like the ACS, CPS, NHIS, and BRFSS are incredibly valuable for researchers and policymakers. (1/7)
The last few weeks saw vital public data from the Census and other government surveys being taken offline. These surveys like the ACS, CPS, NHIS, and BRFSS are incredibly valuable for researchers and policymakers. (1/7)
General public views on Medicaid: www.kff.org/medicaid/pol...
How people with Medicaid coverage view the program: www.kff.org/mental-healt...
General public views on Medicaid: www.kff.org/medicaid/pol...
How people with Medicaid coverage view the program: www.kff.org/mental-healt...
www.kff.org/health-infor...
www.kff.org/health-infor...
Ozempic and Wegovy — the blockbuster GLP-1 weight loss drug — are now officially subject to price negotiation under the Inflation Reduction Act
Negotiated prices apply to Medicare and it’s not yet clear what, if any, spillover effect this might have for people with private insurance
Ozempic and Wegovy — the blockbuster GLP-1 weight loss drug — are now officially subject to price negotiation under the Inflation Reduction Act
Negotiated prices apply to Medicare and it’s not yet clear what, if any, spillover effect this might have for people with private insurance